CCCCC4 Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+33% of shares).
Rangebound, no clear trend. Price is −4% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CCCC is trading
C4 Therapeutics, Inc. is +34% over the past year while the S&P 500 is +16%: 18 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −4.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 52
RSI (14) · neutral
- Below its 52-week high
- 35%
Below its 52-week high
Details›
- Last close2026-10-23
- $3.05
- 1 monthS&P 500 −0.94%
- +0.66%
- 1 yearS&P 500 +16%
- +34%
- 5 yearsS&P 500 +86%
- −93%
- vs 50-day average$3.41
- −11%
- 52-week high
- $4.67
- 52-week low
- $1.71
- Annualised volatility
- 92%
| Year | Return |
|---|---|
| 2026 (year to date) | +60% |
| 2025 | −47% |
| 2024 | −36% |
| 2023 | −4.2% |
| 2022 | −82% |
| 2021 | −2.8% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +3.7% |
| Feb | 6 | 3 of 6 | +13% |
| Mar | 6 | 1 of 6 | −19% |
| Apr | 6 | 2 of 6 | −15% |
| May | 6 | 3 of 6 | +3.1% |
| Jun | 6 | 4 of 6 | +0.18% |
| Jul | 6 | 5 of 6 | +24% |
| Aug | 6 | 3 of 6 | −0.09% |
| Sep | 6 | 1 of 6 | −12% |
| Oct | 6 | 2 of 6 | −1.4% |
| Nov | 6 | 3 of 6 | +1.6% |
| Dec | 6 | 1 of 6 | +25% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.